DE69402576T2 - Cytotoxische und antivirale Verbindung - Google Patents

Cytotoxische und antivirale Verbindung

Info

Publication number
DE69402576T2
DE69402576T2 DE69402576T DE69402576T DE69402576T2 DE 69402576 T2 DE69402576 T2 DE 69402576T2 DE 69402576 T DE69402576 T DE 69402576T DE 69402576 T DE69402576 T DE 69402576T DE 69402576 T2 DE69402576 T2 DE 69402576T2
Authority
DE
Germany
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69402576T
Other languages
English (en)
Other versions
DE69402576D1 (de
Inventor
Paul J Schauer
Mark T Hamann
Dolores G C O Pharma Gravalos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Publication of DE69402576D1 publication Critical patent/DE69402576D1/de
Application granted granted Critical
Publication of DE69402576T2 publication Critical patent/DE69402576T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69402576T 1993-02-03 1994-02-02 Cytotoxische und antivirale Verbindung Expired - Lifetime DE69402576T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (2)

Publication Number Publication Date
DE69402576D1 DE69402576D1 (de) 1997-05-22
DE69402576T2 true DE69402576T2 (de) 1997-10-02

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69402576T Expired - Lifetime DE69402576T2 (de) 1993-02-03 1994-02-02 Cytotoxische und antivirale Verbindung

Country Status (11)

Country Link
EP (1) EP0610078B1 (de)
JP (1) JP3452628B2 (de)
AT (1) ATE151776T1 (de)
AU (1) AU677258B2 (de)
CA (1) CA2114859C (de)
DE (1) DE69402576T2 (de)
DK (1) DK0610078T3 (de)
ES (1) ES2102772T3 (de)
GB (1) GB9302046D0 (de)
GR (1) GR3024028T3 (de)
ZA (1) ZA94748B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
HUP0600031A3 (en) 2000-10-31 2012-02-28 Pharma Mar Kahalalide formulations and their use
EP1435990A1 (de) * 2001-10-19 2004-07-14 Pharma Mar, S.A. Kahalalid-verbindungen zur verwendung in der krebstherapie
JP4430009B2 (ja) * 2002-10-18 2010-03-10 ファーマ・マール・エス・アー・ウー 新規な抗腫瘍化合物
KR101149095B1 (ko) * 2002-10-18 2012-05-30 파르마 마르 에스.에이.유. 4-메틸헥사노 카할라리드 ｆ 화합물
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
MX2010009782A (es) * 2008-03-07 2010-09-30 Pharma Mar Sa Tratamientos antitumorales mejorados.
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE83480T1 (de) * 1988-09-05 1993-01-15 Sankyo Co Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
DE69402576D1 (de) 1997-05-22
DK0610078T3 (da) 1997-10-20
ES2102772T3 (es) 1997-08-01
AU5491194A (en) 1994-08-11
ATE151776T1 (de) 1997-05-15
JPH0770185A (ja) 1995-03-14
ZA94748B (en) 1994-09-29
GB9302046D0 (en) 1993-03-24
JP3452628B2 (ja) 2003-09-29
EP0610078B1 (de) 1997-04-16
CA2114859A1 (en) 1994-08-04
EP0610078A1 (de) 1994-08-10
CA2114859C (en) 2008-04-15
AU677258B2 (en) 1997-04-17
GR3024028T3 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
HUT67742A (en) Phosphono-oxymethyl-ethers of taxane derivatives
IL94915A (en) Substituted quinazolinones and pharmaceutical compositions containing them
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
FI905983A (fi) Aminosyraderivat.
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
SE8704298D0 (sv) Compounds for use in therapy
TW226375B (de)
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
TW280813B (de)
DE69402576D1 (de) Cytotoxische und antivirale Verbindung
CA2152771A1 (en) 7-o-ethers of taxane derivatives
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
IL107321A0 (en) Substituted azetidinones, their preparation and pharmaceutical compositions comprising them
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
ITRM920930A1 (it) Impiego del glutatione per la preparazione di composizioni farmaceutiche ad attivita' antivirale.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MOSELPATENT TRIERPATENT, 54290 TRIER

8328 Change in the person/name/address of the agent

Representative=s name: PATENTANWAELTE SERWE & DR. WAGNER, 54290 TRIER